Hepatitis C Articles (HCV)
Abbvie (formerly Abbott) HCV Drug Program
Abbvie is currently in a large phase 3 trials program, its expected that by June 2014 Abbvie will submit to the FDA a New drug approval application for this new HCV IFN-free regimen, standard procedure for new drug approvals......
SAFETY AND EFFICACY OF INTERFERON-FREE REGIMENS OF ABT-450/r, ABT-267, ABT-333 +/- RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GT1 INFECTION: RESULTS FROM THE AVIATOR STUDY
SAFETY OF RIBAVIRIN-CONTAINING REGIMENS OF ABT-450/r, ABT-333, AND ABT-267 FOR THE TREATMENT OF HCV GENOTYPE 1 INFECTION AND EFFICACY IN SUBJECTS WITH RIBAVIRIN DOSE REDUCTIONS
View Older Articles
Back to Top